Underinsurance Tied to Higher Death Risk After Cardio Events

This article originally appeared here.
Share this content:
Underinsurance Tied to Higher Death Risk After Cardio Events
Underinsurance Tied to Higher Death Risk After Cardio Events

(HealthDay News) – Being underinsured correlates with increased mortality after acute cardiovascular events, while race is not associated with increased mortality, according to a study published online July 21 in the Journal of General Internal Medicine.

Derek K. Ng, ScM, from the Johns Hopkins Bloomberg School of Public Health in Baltimore, MD, and colleagues examined the relative risk of death associated with insurance and race in a cohort of 4,908 patients with acute myocardial infarction, 6,759 with coronary atherosclerosis, and 1,293 with stroke; all were admitted to 3 hospitals with unique demographics in Maryland between 1993 and 2007.

The researchers found that being underinsured correlated with an increased risk of death after myocardial infarction (relative hazard, 1.31), coronary atherosclerosis (relative hazard, 1.50), or stroke (relative hazard, 1.25; 95% confidence interval [CI], 0.91–1.72), after adjustment for race, disease severity, location, neighborhood socioeconomic status, and other factors. Among blacks, there was no increased risk of death after myocardial infarction (relative hazard, 1.03; 95% CI, 0.85–1.24) or after stroke (relative hazard, 1.18; 95% CI, 0.86–1.61). Black race was associated with a significantly decreased risk of death after coronary atherosclerosis (relative hazard, 0.82).

"Our results support growing evidence implicating insurance status and socioeconomic factors as important drivers of health disparities, and potentially racial disparities," the authors write.

Abstract
Full Text

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs